2015 annual financial data

Regeneron Pharmaceuticals 2015 Net margin

Regeneron Pharmaceuticals 2015 net margin with verified reported values.

Direct answer

Net margin was 15.5%.

Operating income was 1,251,916,000 USD and net income was 636,056,000 USD.
Operating cash flow was 1,330,780,000 USD.

Get free Regeneron Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
4,103,728,000 USD
Operating income
1,251,916,000 USD
Net income
636,056,000 USD
Operating cash flow
1,330,780,000 USD